49

Listed companies

12

Private companies

126

Insiders

Relation chart of related listed companies: H. Lundbeck A/S

Active Relations

Past Relations

Related listed companies: H. Lundbeck A/S

Active Relations

Past Relations

Relationship chart for related private companies: H. Lundbeck A/S

Active Relations

Past Relations

Related private companies: H. Lundbeck A/S

Biotechnology Innovation Organization

Miscellaneous Commercial Services

Karo Healthcare AB

Household/Personal Care

Lundbeckfonden

Investment Trusts/Mutual Funds

Falck A/S

Services to the Health Industry

University of Copenhagen

Other Consumer Services

Pharmaceutical Research & Manufacturers of America

Biotechnology

European Federation of Pharmaceutical Industries & Assns

Miscellaneous Commercial Services

Pharmacosmos A/S

Biotechnology

Lundbeck Pharma A/S

Medical Distributors

Pharma Guidance ApS

Miscellaneous Commercial Services

WS Audiology A/S

Medical Specialties

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major15
Biotechnology13
Medical Specialties6
Medical Distributors3
Miscellaneous Commercial Services3
Electrical Products1
Construction Materials1
Air Freight/Couriers1
Marine Shipping1
Publishing: Books/Magazines1

Countries of related companies

Denmark23
Sweden16
United States12
Belgium3
France2
Germany2
Finland1
Turkey1
Australia1
Logo H. Lundbeck A/S
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.
Employees
5,039